Plasma Exosome Profile in ST-Elevation Myocardial Infarction Patients with and without Out-of-Hospital Cardiac Arrest
Creators
- Marta Zarà1
- Jeness Campodonico1
- Nicola Cosentino1
- Maria Luisa Biondi1
- Patrizia Amadio1
- Gloria Milanesi2
- Emilio Assanelli1
- Silvia Cerri3
- Marco Biggiogera2
- Leonardo Sandrini1
- Calogero Claudio Tedesco1
- Fabrizio Veglia1
- Daniela Trabattoni1
- Fabio Blandini3
- Elena Tremoli4
- Giancarlo Marenzi1
- Silvia Stella Barbieri1
- 1. Centro Cardiologico Monzino
- 2. Università di Pavia
- 3. Fondazione Mondino
- 4. Maria Cecilia Hospital
Description
This dataset is related to the article: Plasma Exosome Profile in ST-Elevation Myocardial Infarction Patients with and without Out-of-Hospital Cardiac Arrest.
The identification of new biomarkers allowing an early and more accurate characterization of patients with ST-segment elevation myocardial infarction (STEMI) is still needed, and exosomes represent an attractive diagnostic tool in this context. However, the characterization of their protein cargo in relation to cardiovascular clinical manifestation is still lacking. To this end, 35 STEMI patients (17 experiencing resuscitated out-of-hospital cardiac arrest (OHCA-STEMI) and 18 uncomplicated) and 32 patients with chronic coronary syndrome (CCS) were enrolled. Plasma exosomes were characterized by the nanoparticle tracking analysis and Western blotting. Exosomes from STEMI patients displayed a higher concentration and size and a greater expression of platelet (GPIIb) and vascular endothelial (VE-cadherin) markers, but a similar amount of cardiac troponin compared to CCS. In addition, a difference in exosome expression of acute-phase proteins (ceruloplasmin, transthyretin and fibronectin) between STEMI and CCS patients was found. GPIIb and brain-associated marker PLP1 accurately discriminated between OHCA and uncomplicated STEMI. In conclusion, the exosome profile of STEMI patients has peculiar features that differentiate it from that of CCS patients, reflecting the pathophysiological mechanisms involved in STEMI. Additionally, the exosome expression of brain- and platelet-specific markers might allow the identification of patients experiencing ischemic brain injury in STEMI.
Notes
Files
Additional details
Related works
- Is supplemented by
- Journal article: 10.3390/ijms22158065 (DOI)